YOLFTbeta
Inspire Medical Systems Inc

Inspire Medical Systems Inc

INSP · NYSE · Healthcare / Medical Devices

61.10USD+0.56 (+0.93%)

Price History

Full chart

Market Stats

Previous Close60.54
Open61.11
Day Range60.12 – 61.47
52-Week Range38.91 – 147.03
Volume574.38K
Market Cap2.02B
P/E (TTM)15.45
Forward P/E59.17
EPS4.53
Dividend Yield0.00%
Beta0.70
50-Day Avg61.68
200-Day Avg62.54

About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Timothy P. Herbert
  • Employees1.33K
  • Headquarters5500 Wayzata Blvd., Golden Valley, MN, United States, 55416, USA
  • Websitehttps://www.inspiresleep.com

Leadership

  • Mr. Timothy P. HerbertFounder, Chairman, CEO & President · b. 1963
  • Mr. Bryan K. Phillips J.D.Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary · b. 1971
  • Mr. Carlton W. WeatherbyChief Strategy and Growth Officer · b. 1985
  • Mr. Matthew J. OsbergExecutive VP & CFO · b. 1977
  • Mr. Jason P. KellyChief Operations & Innovation Officer · b. 1980
  • Ms. Melissa J. MannChief People Officer · b. 1976
  • Mr. Ivan LubogoSVP of Strategic Sales
  • Mr. Andreas HenkeExecutive VP International & MD
  • Mr. Joseph E. SanderSenior Vice President of U.S. Sales
  • Ms. Megan Rowekamp CPADirector of Financial Reporting

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.01M16.43M28.57M50.59M82.05M115.38M233.39M407.86M624.80M802.80M911.98M
Growth (%)-+105.03%+73.90%+77.10%+62.18%+40.62%+102.28%+74.75%+53.19%+28.49%+13.60%
Cost of Revenue2.81M3.90M6.02M10.06M13.64M17.62M33.28M66.11M96.58M122.99M133.22M
Gross Profit5.20M12.52M22.55M40.54M68.41M97.76M200.12M341.74M528.22M679.82M778.76M
Gross Margin64.94%76.23%78.93%80.12%83.37%84.73%85.74%83.79%84.54%84.68%85.39%
Operating Expense25.00M29.77M38.55M60.91M103.30M153.97M239.97M389.33M568.49M643.74M727.80M
Operating Income-19.80M-17.25M-16.00M-20.38M-34.90M-56.21M-39.85M-47.59M-40.27M36.08M50.95M
Operating Margin-247.10%-105.03%-56.02%-40.28%-42.53%-48.72%-17.07%-11.67%-6.45%4.49%5.59%
EBITDA-19.65M-17.12M-15.47M-18.13M-30.59M-54.13M-38.62M-40.73M-40.27M65.03M79.79M
EBITDA Margin-245.29%-104.23%-54.16%-35.84%-37.28%-46.92%-16.55%-9.99%-6.45%8.10%8.75%
Net Income-21.34M-18.53M-17.51M-21.83M-33.24M-57.20M-42.04M-44.88M-21.15M53.51M145.42M
Net Income Margin-266.31%-112.79%-61.30%-43.14%-40.52%-49.58%-18.01%-11.00%-3.39%6.67%15.95%
R&D7.08M7.09M6.19M7.39M12.84M26.09M37.35M68.64M116.54M114.13M103.17M
R&D as % of Total Revenue88.35%43.17%21.68%14.60%15.65%22.61%16.00%16.83%18.65%14.22%11.31%
Interest Expense1.56M1.30M1.75M3.30M2.12M2.12M2.13M1.68M022.00K137.00K
Interest Expense % of Total Revenue19.52%7.93%6.14%6.53%2.58%1.83%0.91%0.41%0.00%0.00%0.02%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-13.12M25.09M200.08M181.25M281.19M295.08M564.88M676.81M808.38M907.32M
Total Liabilities-19.72M23.61M36.08M41.42M51.44M66.04M68.87M104.30M118.69M126.16M
Total Equity--6.61M1.48M164.00M139.84M229.75M229.05M496.01M572.51M689.70M781.16M
Cash-6.68M8.96M97.29M22.86M190.52M214.47M441.59M185.54M150.15M104.81M
Total Debt-15.69M16.46M24.93M25.35M30.63M34.09M16.41M24.85M31.79M32.16M
Net Debt-9.01M7.50M-72.36M1.66M-159.89M-180.37M-425.18M-160.69M-118.36M-72.66M

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-22.25M-17.95M-15.79M-18.69M-33.38M-53.05M-20.12M11.57M24.65M130.25M116.98M
Investing Cash Flow23.56M-306.00K-7.60M-83.39M-43.56M86.63M29.14M-19.60M-294.82M-113.12M21.45M
Financing Cash Flow2.54M12.81M25.66M190.38M2.50M134.06M14.95M235.08M13.95M-52.39M-183.45M
Capital Expenditure346.00K306.00K412.00K250.00K2.74M2.46M4.67M9.10M23.63M39.12M38.50M
Free Cash Flow-22.60M-18.25M-16.20M-18.94M-35.59M-55.50M-24.79M2.47M1.02M91.12M78.48M
FCF to OCF101.55%101.70%102.61%101.34%106.62%104.63%123.20%21.38%4.15%69.96%67.09%

Earnings

Report DateMay 4, 2017Feb 28, 2018Jun 7, 2018Aug 7, 2018Nov 6, 2018Feb 26, 2019May 7, 2019Aug 6, 2019Nov 5, 2019Feb 25, 2020May 5, 2020Aug 4, 2020Nov 2, 2020Feb 23, 2021May 4, 2021Aug 3, 2021Nov 2, 2021Feb 8, 2022May 3, 2022Aug 2, 2022Nov 1, 2022Feb 7, 2023May 2, 2023Aug 1, 2023Nov 7, 2023Feb 6, 2024May 7, 2024Aug 6, 2024Nov 4, 2024Feb 10, 2025May 5, 2025Aug 4, 2025Nov 3, 2025Feb 11, 2026May 4, 2026Aug 3, 2026Nov 2, 2026
EPS Estimate0.000.00-3.64-0.48-0.34-0.31-0.38-0.43-0.41-0.40-0.60-1.14-0.73-0.48-0.64-0.66-0.64-0.46-0.83-0.63-0.79-0.54-0.70-0.58-0.57-0.09-0.67-0.110.080.72-0.230.20-0.170.68-0.26-0.220.10
EPS Actual-3.90-3.46-5.05-0.43-0.22-0.22-0.35-0.32-0.34-0.38-0.67-0.88-0.39-0.28-0.60-0.48-0.38-0.09-0.61-0.53-0.600.10-0.53-0.41-0.290.49-0.340.320.601.150.100.450.381.650.100.14-
Surprise---38.74%10.42%35.29%29.03%7.89%25.58%17.07%5.00%-11.67%22.81%46.58%41.67%6.25%27.27%40.63%80.43%26.51%15.87%24.05%118.52%24.29%29.31%49.12%644.44%49.25%390.91%650.00%59.72%143.48%125.00%323.53%142.65%138.46%163.64%-
Timing--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.02B
Enterprise Value1.70B
Trailing P/E15.45
Forward P/E59.17
Price / Sales2.25
Price / Book2.42
EPS4.53
Book Value28.56
Revenue (TTM)898.74M
Gross Profit (TTM)774.11M
EBITDA71.33M
Profit Margin15.03%
Operating Margin-0.26%
Return on Equity17.97%
Return on Assets3.92%
Shares Outstanding28.91M
Shares Float23.28M
Beta0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 18 analystsTarget 62.80
  • Strong Buy
    8
  • Buy
    5
  • Hold
    5

Ownership Breakdown

Institutions
130.30%
Insiders
1.18%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    3.55M12.28%
  • Deerfield Management Co
    2.70M9.35%
  • Wellington Management Company LLP
    2.38M8.24%
  • Soleus Capital Management, L.P.
    1.93M6.68%
  • Vanguard Portfolio Management, LLC
    1.64M5.66%
  • D. E. Shaw & Co LP
    1.47M5.09%
  • Morgan Stanley - Brokerage Accounts
    1.45M5.02%
  • Nomura Holdings Inc
    1.37M4.74%
  • Vanguard Capital Management, LLC
    1.27M4.38%
  • State Street Corp
    956.01K3.31%
  • Assenagon Asset Management SA
    864.39K2.99%
  • Artisan Partners Limited Partnership
    732.32K2.53%
  • BRAIDWELL LP
    677.57K2.34%
  • The Goldman Sachs Group Inc
    664.00K2.30%
  • UBS Group AG
    638.93K2.21%

Top Fund Holders

  • Vanguard Health Care Inv
    2.09M7.24%
  • iShares Core S&P Small-Cap ETF
    1.60M5.53%
  • Vanguard MStar Total Stk Mkt Idx Invest
    914.15K3.16%
  • iShares Russell 2000 ETF
    739.27K2.56%
  • Vanguard Small Cap Index
    662.34K2.29%